Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 1, 2009, Pages 80-82

  Pérez Grande, Rosa ^a   Gutiérrez Zufiaurre, Nieves ^a   Muñoz Criado, Santiago ^a,b   Blázquez de Castro, Ana M ^a   Vázquez López, Lourdes ^a   González San Martín, Francisco ^a   García Rodríguez, Jose Angel ^a,b   Muñoz Bellido, Juan Luis ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Hepatitis B; Immunosuppression; Lamivudine; Reactivation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; GANCICLOVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; METHYLPREDNISOLONE; TACROLIMUS; ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHEMOTHERAPY; CYTOMEGALOVIRUS ANTIGENEMIA; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HEPATITIS B; HUMAN; LABORATORY TEST; LIVER FUNCTION TEST; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROPHYLAXIS; RASH; REFRACTORY ANEMIA WITH EXCESS BLASTS; SEROCONVERSION; SKIN MANIFESTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS REACTIVATION; BLOOD; BONE MARROW TRANSPLANTATION;

ADULT; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LAMIVUDINE;

EID: 65649094781     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.01.007     Document Type: Article

References (11)

1. Cheng A.L., Hsiung C.A., Su L.J., Chen P.J., Chang M.C., Tsao C.J., Kau W.Y., Uen W.C., Hsu C.H., Tien H.F., Chen L.T., and Whang-Peng J. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 37 (2003) 1320-1328
2. Colson P., Borentain P., Coso D., Chabannon C., Tamalet C., and Gerolami R. Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma. Br. J. Haematol. 143 (2008) 148-150
3. Garcia-Rodriguez M.J., Canales M.A., Hernandez-Maraver D., and Hernandez-Navarro F. Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?. Am. J. Hematol. 83 (2008) 673-675
4. Hsu C., Hsiung C.A., Su I.J., Hwang W.S., Wang M.C., Lin S.F., Lin T.H., Hsiao H.H., Young J.H., Chang M.C., Liao Y.M., Li C.C., Wu H.B., Tien H.F., Chao T.Y., Liu T.W., Cheng A.L., and Chen P.J. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology 47 (2008) 844-853
5. Lalazar G., Rund D., and Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br. J. Haematol. 136 (2007) 699-712
6. Law J.K., Ho J.K., Hoskins P.J., Erb S.R., Steinbrecher U.P., and Yoshida E.M. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk. Lymphoma 46 (2005) 1085-1089
7. Lok A.S., Liang R.H., Chiu E.K., Wong K.L., Chan T.K., and Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study. Gastroenterology 100 (1991) 182-188
8. Sera T., Hiasa Y., Michitaka K., Konishi I., Matsuura K., Tokumoto Y., Matsuura B., Kajiwara T., Masumoto T., Horiike N., and Onji M. Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern. Med. 45 (2006) 721-724
9. Sherman M., Yurdaidin C., Sollano J., Silva M., Liaw Y.F., Cianciara J., Boron-Kaczmarska A., Martin P., Goodman Z., Colonno R., Cross A., Denisky G., Kreter B., Hindes R., and AI463026 BEHoLD Study Group. Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B. Gastroenterology 130 (2006) 2039-2049
10. Thirot-Bidault A., Ben Mansour J., Lambotte O., Besson C., Bou-Farah R., Pallier C., and Buffet C. Fatal liver failure after hepatitis B reactivation following chemotherapy for lymphoma in a patient with only anti-HBc antibody and review of the literature. Gastroenterol. Clin. Biol. 31 (2007) 1028-1031
11. Tsutsumi Y., Kanamori H., Mori A., Tanaka J., Asaka M., Imamura M., and Masauzi N. Reactivation of hepatitis B virus with rituximab. Expert Opin. Drug Saf. 4 (2005) 599-608